The Space Between Reaction and Regulation
Begin
Notice · Interrupt & Identify · Regulate
Nirva Institute
Research Roadmap
How the Institute intends to develop Nervous System Intelligence from framework to field.
This is not a research prospectus. It is a public commitment to the sequence of work required to move NSI from a proposition into a discipline other researchers, clinicians, and educators can extend.
Phase 01 — Definition
- Publish the founding NSI white paper (complete).
- Establish official terminology and canonical definitions (in progress).
- Articulate proposed models with clear scope, limitations, and testable predictions.
- Distinguish established findings from Nirva Life’s synthesis and from proposed models.
Phase 02 — Collaboration
- Invite comment and critique from neuroscience, psychology, medicine, behavioral science, education, and rehabilitation.
- Establish an external scientific advisory circle.
- Pursue two university research partnerships focused on measurable NSI applications.
- Formalize institutional review and ethics oversight for any human-subjects work.
Phase 03 — Instrumentation
- Refine the Framework Reflection as a research-grade reflective instrument.
- Develop the anonymized experience dataset produced by I’mPossible™ as a novel scientific resource.
- Publish methodology papers before publishing outcomes.
Phase 04 — Publication
- Institute position papers on the core NSI concepts (Experience Loop, Invisible Patterns, Contextual Regulation, Nervous System Literacy).
- Peer-reviewed empirical work in collaboration with university partners.
- Open-access clinical and educational applications.
Phase 05 — Translation
- Translate evidence into educational curricula (Nirva Academy).
- Translate evidence into clinical decision-support (NirvaCare™).
- Translate evidence into organizational literacy programs.
What we will not do
- We will not claim clinical validation before it exists.
- We will not brand NSI as a therapy or medical treatment.
- We will not publish outcomes without publishing methods.
- We will not collect sensitive health information through public marketing surfaces.